Association of Serum C-Peptide Concentrations with Cancer Mortality Risk in Pre-Diabetes or Undiagnosed Diabetes

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hsu, Chih Neng ^a   Chang, Chia Hsuin ^a,b   Lin, Yu Sheng ^c,d   Lin, Jou Wei ^a,b   Caffrey, James L ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

ADULT; AGED; BIOLOGICAL MARKERS; C-PEPTIDE; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PREDIABETIC STATE; PROGNOSIS; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 84873542001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055625     Document Type: Article

References (35)

1. Wild SH, (2011) Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations. Diabetologia 54 (7) (): 1589-92.
2. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. Diabetes Care 33: 1674-1685.
3. Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, et al. (2012) Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results From a Large Population-based Follow-up Study. Diabetes Care 35 (1) (): 119-24.
4. Chang CH, Toh S, Lin JW, Chen ST, Kuo CW, et al. (2011) Cancer risk associated with insulin glargine among adult type 2 diabetes patients-a nationwide cohort study. PLoS One 6: e21368.
5. Chang CH, Lin JW, Wu LC, Lai MS, (2011) Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study. J Clin Oncol 29: 3001-3007.
6. Friis S, Poulsen AH, Johnsen SP, McLaughlin JK, Fryzek JP, et al. (2005) Cancer risk among statin users: a population-based cohort study. Int J Cancer 114: 643-647.
7. Yang X, Ko GT, So WY, Ma RC, Yu LW, et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes 59: 1254-1260.
8. Chang KW, Hung PS, Lin IY, Hou CP, Chen LK, et al. (2010) Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer 127: 9-20.
9. Johnson JA, Bowker SL, (2011) Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54: 25-31.
10. Giovannucci E, (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86: s836-842.
11. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, et al. (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94: 1099-1106.
12. National Health and Nutrition Examination Survey, Centers for Disease Control and Prevention. Available: http://www.cdc.gov/nchs/nhanes.htm. Accessed 30 December 2012.
13. Household Adult File, NHANES III. Available: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/1A/ADULT-acc.pdf. Accessed 30 December 2012.
14. Examination File, NHANES III. Available: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/1A/exam-acc.pdf.Accessed 30 December 2012.
15. Vogeser M, Konig D, Frey I, Predel HG, Parhofer KG, et al. (2007) Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons. Clin Biochem 40: 964-968.
16. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, et al. (2000) Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278: E759-768.
17. Wei W, Kim Y, Boudreau N, (2001) Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am J Public Health 91: 258-264.
18. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) 2009NHANESIII linked mortality file (Database). Hyattsville, MD: National Center for Health Statistics. Available: http://www.cdc.gov/nchs/data_access/data_linkage/mortality.htm. Accessed 30 December 2012.
19. CDC. National Center for Health Statistics (NCHS). 2010. The Thrid National Health and Nutrition Examination Survey 1988-1994. NHANES III Linked Mortality Public-use File. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Hyattsville, Maryland. Available: http://www.cdc.gov/nchs/data_access/data_linkage/mortality/nhanes3_linkage_public_use.htm. Accessed 30 December 2012.
20. Lin YS, Chiu FC, Lin JW, Hwang JJ, Caffrey JL, (2010) Association of albuminuria and cancer mortality. Cancer Epidemiol Biomarkers Prev 19: 2950-2957.
21. Lin JW, Caffrey JL, Chang MH, Lin YS, (2010) Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality-cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 95: 4258-4267.
22. Surplus Sera Laboratory Component: Insulin Like Growth Factor (IGF-I) and IGF Binding Proten-3. Available: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/23a/SSIGF.pdf. Accessed 30 December 2012.
23. Berrigan D, Perkins SN, Haines DC, Hursting SD, (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23: 817-822.
24. Parekh N, Lin Y, Hayes RB, Albu JB, Lu-Yao GL, (2010) Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. Cancer Causes Control 21: 631-642.
25. Sarafidis PA, McFarlane SI, Bakris GL, (2006) Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep 6: 219-224.
26. Hwang JJ, Li HY, Shieh GJ, Chien YF, Hua CH, et al. (2008) Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women-a cross-racial validation. Nutr Metab Cardiovasc Dis 18: 671-677.
27. Irwin ML, Duggan C, Wang CY, Smith AW, McTiernan A, et al. (2011) Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol 29: 47-53.
28. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, et al. (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20: 42-51.
29. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL, (2009) Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 15: 5141-5148.
30. Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, et al. (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14: 65-74.
31. Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D, (2010) The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract 16: 864-873.
32. Parekh N, Roberts CB, Vadiveloo M, Puvananayagam T, Albu JB, et al. (2010) Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). Ann Epidemiol 20: 182-193.
33. Faupel-Badger JM, Berrigan D, Ballard-Barbash R, Potischman N, (2009) Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender. Ann Epidemiol 19: 841-849.
34. Carpentier A, Patterson BW, Leung N, Lewis GF, (2002) Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes 51: 1867-1875.
35. Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E, (2004) Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 14: 195-201.